Back

Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Non-troponin biomarkers in acute coronary syndromes ST-Elevation Myocardial Infarction (STEMI) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Christoph Dietrich Garlichs

Deaconess Hospital Flensburg, Flensburg (Germany)

4 More presentations in this session

Presentation thumbnail
Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom
Doctor K. Sopova (Mannheim, DE)
Abstract
Presentation thumbnail
Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)
Doctor A. Kaura (London, GB)
Abstract Slides Video
Presentation thumbnail
Circulating levels of ST2 are associated with myocardial injury, left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction.
Doctor J. Eritsland (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Non-troponin biomarkers in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources